COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,711 Articles (22,913 medRxiv, 8,798 bioRxiv)

Most recent first Previous |  Page 298: Articles 2971-2980  | Next

Direct pharmacological AMPK activation inhibits mucosal SARS-CoV-2 infection by reducing lipid metabolism, restoring autophagy flux and the type I IFN response
Cottignies-Calamarte, A., Marteau, F., Belouzard, S., Dubuisson, J., Tudor, D., Viollet, B., Bomsel, M.
10.1101/2024.02.29.582713 — Posted: 2024-03-01
Compartment-Specific Antibody Correlates of Protection to SARS-CoV-2 Omicron in Macaques
Tong, X., Wang, Q., Jung, W., Chicz, T. M., Blanc, R., Parker, L. J., Barouch, D. H., McNamara, R. P.
10.1101/2024.03.01.582951 — Posted: 2024-03-01
Long COVID and kidney function: A scoping review protocol
Frediani, M., Ribeiro, H. S., Busatto, G., Carvalho, C., Burdmann, E. A.
10.1101/2024.02.29.24303559 — Posted: 2024-02-29
Oro-faecal transmission of SARS-CoV-2: A systematic review of studies employing viral culture from gastrointestinal and other potential sources
Gandini, S., Conly, J., Spencer, E. A., Evans, D., Rosca, E. C., Brassey, J., Maltoni, S., Onakpoya, I., Pluddemann, A., Jefferson, T., Heneghan, C.
10.1101/2024.02.29.24303532 — Posted: 2024-02-29
Inflammatory proteins as strong predictors of death in COVID-19 patients with coexisting neurological diseases
Zielinska-Turek, J., Turek, G., Lyson, T., Gajewski, J., Zabek, M., Dorobek, M.
10.1101/2024.02.27.24303438 — Posted: 2024-02-29
Ineffectiveness of international travel restrictions to contain spread of the SARS-CoV-2 Omicron BA.1 variant: a continent-wide laboratory-based observational study from Africa
Fischer, C., Maponga, T. G., Yadouleton, A., Abilio, N., Aboce, E., Adewumi, P., Afonso, P., Akorli, J., Andriamandimby, S. F., Anga, L., Ashong, Y., Beloufa, M. A., Bensalem, A., Birtles, R., Magloire Boumba, A. L., Bwanga, F., Chaponda, M., Chibukira, P., Chico, R. M., Chileshe, J., Choga, W., Chongwe, G., Cisse, A., Cisse, F., D Alessandro, U., de Lamballerie, X., de Morais, J. F. M., Derrar, F., Dia, N., Diarra, Y., Doumbia, L., Drosten, C., Dussart, P., Echodu, R., Luedde, T., Eloualid, A., Faye, O., Feldt, T., Fruehauf, A., Gaseitsiwe, S., Halatoko, A., Ilouga, P.-V., Ismael, N., Jambou
10.1101/2024.02.27.24303356 — Posted: 2024-02-29
Implementing remote monitoring for COVID-19 patients in primary care
Koehler, S. M., Holtz, S., Chabiera, P. J., Dauletbaev, N., Deutsch, K., Oftring, Z. S., Lawin, D., Niekrenz, L., Euler, T., Gloeckl, R., Koczulla, R., Rohde, G., Dreher, M., Vogelmeier, C. F., Kuhn, S., Mueller, B. S.
10.1101/2024.02.27.24303073 — Posted: 2024-02-29
Evaluating the impacts of tiered restrictions introduced in England in December 2020 on covid-19 hospitalisations: a synthetic control study.
Zhang, X., Hungerford, D., Green, M., Garcia-Finana, M., Buchan, I., Barr, B.
10.1101/2024.02.28.24303487 — Posted: 2024-02-29
COVID-19 vaccine uptake and associated risk factors among first antenatal care attendees in Zambia, 2021-2022: a repeated cross-sectional study
Tembo, T., Heilmann, E., Somwe, P., Bosomprah, S., Kalenga, K., Moyo, N., Kabamba, B., Seffren, V., Fwoloshi, S., Rutagwera, M.-R., Musunse, M., Mwiinga, L., Gutman, J. R., Hines, J. Z., Sikazwe, I.
10.1101/2024.02.27.24303454 — Posted: 2024-02-29
Implementation and Adherence to Regular Asymptomatic Testing in a COVID-19 Vaccine Trial
Williams, L. R., Emary, K. R., Phillips, D. J., Hay, J., Larwood, J. P., Ramasamy, M. N., Pollard, A. J., Grassly, N. C., Voysey, M.
10.1101/2024.02.28.24303505 — Posted: 2024-02-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).